HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nitrosative stress-induced s-glutathionylation of protein disulfide isomerase leads to activation of the unfolded protein response.

Abstract
The rapid proliferation of cancer cells mandates a high protein turnover. The endoplasmic reticulum (ER) is intimately involved in protein processing. An accumulation of unfolded or misfolded proteins in the ER leads to a cascade of transcriptional and translational events collectively called the unfolded protein response (UPR). Protein disulfide isomerase (PDI) is one of the most abundant ER proteins and maintains a sentinel function in organizing accurate protein folding. Treatment of cells with O(2)-[2,4-dinitro-5-(N-methyl-N-4-carboxyphenylamino)phenyl]1-(N,N-dimethylamino)diazen-1-ium-1,2-diolate (PABA/NO) resulted in a dose-dependent increase in intracellular nitric oxide that caused S-glutathionylation of various proteins. Within 4 h, PABA/NO activated the UPR and led to translational attenuation as measured by the phosphorylation and activation of the ER transmembrane kinase, pancreatic ER kinase, and its downstream effector eukaryotic initiation factor 2 in human leukemia (HL60) and ovarian cancer cells (SKOV3). Cleavage of the transcription factor X-box protein 1 and transcriptional activation of the ER resident proteins BiP, PDI, GRP94, and ERO1 (5- to 10-fold induction) also occurred. Immunoprecipitation of PDI showed that whereas nitrosylation was undetectable, PABA/NO treatment caused S-glutathionylation of PDI. Mass spectroscopy analysis showed that single cysteine residues within each of the catalytic sites of PDI had a mass increase [+305.3 Da] consistent with S-glutathionylation. Circular dichroism confirmed that S-glutathionylation of PDI results in alterations in the alpha-helix content of PDI and is concurrent with inhibition of its isomerase activity. Thus, it appears that S-glutathionylation of PDI is an upstream signaling event in the UPR and may be linked with the cytotoxic potential of PABA/NO.
AuthorsDanyelle M Townsend, Yefim Manevich, Lin He, Ying Xiong, Robert R Bowers Jr, Steven Hutchens, Kenneth D Tew
JournalCancer research (Cancer Res) Vol. 69 Issue 19 Pg. 7626-34 (Oct 01 2009) ISSN: 1538-7445 [Electronic] United States
PMID19773442 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Azo Compounds
  • O(2)-(2,4-dinitro-5-(N-methyl-N-4-carboxyphenylamino)phenyl 1-N,N-dimethylamino)diazen-1-ium-1,2-diolate
  • para-Aminobenzoates
  • Nitric Oxide
  • Protein Disulfide-Isomerases
  • Glutathione
  • Cysteine
  • 4-Aminobenzoic Acid
Topics
  • 4-Aminobenzoic Acid (pharmacology)
  • Amino Acid Sequence
  • Azo Compounds (pharmacology)
  • Catalytic Domain
  • Cell Line, Tumor
  • Cysteine (metabolism)
  • Female
  • Glutathione (metabolism)
  • HL-60 Cells
  • Humans
  • Models, Molecular
  • Molecular Sequence Data
  • Neoplasms (drug therapy, enzymology, metabolism)
  • Nitric Oxide (metabolism)
  • Ovarian Neoplasms (drug therapy, enzymology, metabolism)
  • Protein Disulfide-Isomerases (metabolism)
  • Protein Folding
  • Proteomics (methods)
  • Structure-Activity Relationship
  • para-Aminobenzoates

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: